Literature DB >> 7790096

Shiga toxin-associated hemolytic uremic syndrome: effect of sodium butyrate on sensitivity of human umbilical vein endothelial cells to Shiga toxin.

C B Louise1, S A Kaye, B Boyd, C A Lingwood, T G Obrig.   

Abstract

Escherichia coli O157:H7-related vascular damage such as hemolytic uremic syndrome is believed to require the Shiga-like toxins. This study demonstrated that sodium butyrate sensitized human umbilical vein endothelial cells to Shiga toxin and increased the expression of Shiga toxin receptor, globotriaosylceramide (Gb3), on human umbilical vein endothelial cells.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7790096      PMCID： PMC173370          DOI： 10.1128/iai.63.7.2766-2769.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  29 in total

1.  Induction of verotoxin sensitivity in receptor-deficient cell lines using the receptor glycolipid globotriosylceramide.

Authors:  T Waddell; A Cohen; C A Lingwood
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

2.  Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum.

Authors:  K Sandvig; O Garred; K Prydz; J V Kozlov; S H Hansen; B van Deurs
Journal:  Nature       Date:  1992-08-06       Impact factor: 49.962

3.  Evaluation of the role of Shiga and Shiga-like toxins in mediating direct damage to human vascular endothelial cells.

Authors:  V L Tesh; J E Samuel; L P Perera; J B Sharefkin; A D O'Brien
Journal:  J Infect Dis       Date:  1991-08       Impact factor: 5.226

4.  Preparation of VT1 and VT2 hybrid toxins from their purified dissociated subunits. Evidence for B subunit modulation of a subunit function.

Authors:  S C Head; M A Karmali; C A Lingwood
Journal:  J Biol Chem       Date:  1991-02-25       Impact factor: 5.157

5.  A novel microtiter plate assay for the quantitation of procoagulant activity on adherent monocytes, macrophage and endothelial cells.

Authors:  Y M Surprenant; S H Zuckerman
Journal:  Thromb Res       Date:  1989-02-01       Impact factor: 3.944

6.  The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections.

Authors:  S E Richardson; M A Karmali; L E Becker; C R Smith
Journal:  Hum Pathol       Date:  1988-09       Impact factor: 3.466

7.  Shiga toxin-associated hemolytic-uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1 beta, and tumor necrosis factor alpha on human vascular endothelial cells in vitro.

Authors:  C B Louise; T G Obrig
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

8.  Cloning and sequencing of the genes for Shiga toxin from Shigella dysenteriae type 1.

Authors:  N A Strockbine; M P Jackson; L M Sung; R K Holmes; A D O'Brien
Journal:  J Bacteriol       Date:  1988-03       Impact factor: 3.490

9.  Binding of verocytotoxin 1 to its receptor is influenced by differences in receptor fatty acid content.

Authors:  A Pellizzari; H Pang; C A Lingwood
Journal:  Biochemistry       Date:  1992-02-11       Impact factor: 3.162

10.  Endocytosis and intracellular transport of the glycolipid-binding ligand Shiga toxin in polarized MDCK cells.

Authors:  K Sandvig; K Prydz; M Ryd; B van Deurs
Journal:  J Cell Biol       Date:  1991-05       Impact factor: 10.539
View more
  8 in total

1.  Baicalin inhibits the lethality of Shiga-like toxin 2 in mice.

Authors:  Jing Dong; Yong Zhang; Yutao Chen; Xiaodi Niu; Yu Zhang; Cheng Yang; Quan Wang; Xuemei Li; Xuming Deng
Journal:  Antimicrob Agents Chemother       Date:  2015-09-08       Impact factor: 5.191

Review 2.  Facing glycosphingolipid-Shiga toxin interaction: dire straits for endothelial cells of the human vasculature.

Authors:  Andreas Bauwens; Josefine Betz; Iris Meisen; Björn Kemper; Helge Karch; Johannes Müthing
Journal:  Cell Mol Life Sci       Date:  2012-07-06       Impact factor: 9.261

3.  Differences in virulence among Escherichia coli O157:H7 strains isolated from humans during disease outbreaks and from healthy cattle.

Authors:  Diane R Baker; Rodney A Moxley; Mike B Steele; Jeffrey T Lejeune; Jane Christopher-Hennings; Ding-Geng Chen; Philip R Hardwidge; David H Francis
Journal:  Appl Environ Microbiol       Date:  2007-09-21       Impact factor: 4.792

4.  Differentiation-associated toxin receptor modulation, cytokine production, and sensitivity to Shiga-like toxins in human monocytes and monocytic cell lines.

Authors:  B Ramegowda; V L Tesh
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

Review 5.  Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections.

Authors:  J C Paton; A W Paton
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

6.  Role of nitric oxide in shiga toxin-2-induced premature delivery of dead fetuses in rats.

Authors:  Juliana Burdet; Elsa Zotta; Maximiliano Cella; Ana M Franchi; Cristina Ibarra
Journal:  PLoS One       Date:  2010-12-29       Impact factor: 3.240

Review 7.  Shiga toxin interaction with human intestinal epithelium.

Authors:  Stephanie Schüller
Journal:  Toxins (Basel)       Date:  2011-06-14       Impact factor: 4.546

8.  Shiga toxin type 2dact displays increased binding to globotriaosylceramide in vitro and increased lethality in mice after activation by elastase.

Authors:  Joshua C Bunger; Angela R Melton-Celsa; Alison D O'Brien
Journal:  Toxins (Basel)       Date:  2013-11-08       Impact factor: 4.546
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.